Progestogen Hypersensitivity : An Evidence-Based Approach to Diagnosis and Management in Clinical Practice
Copyright © 2017 Elsevier Inc. All rights reserved..
Heterogeneous presentations of disease pose particular diagnostic and management challenges to the clinician. Progestogen hypersensitivity (PH) classically consists of hypersensitivity symptoms to endogenous progesterone during the luteal phase of the menstrual cycle. However, with the rise of assisted fertility and the exponential growth in the use of exogenous progestins for contraception, PH's prevalence and symptom heterogeneity have increased. In this article, we focus on the clinical approach to PH diagnosis with an emphasis on key elements of the history, physical, and testing modalities. We also review the current evidence for successful management and treatment across a broad range of patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Immunology and allergy clinics of North America - 37(2017), 4 vom: 01. Nov., Seite 773-784 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Foer, Dinah [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Autoimmune progesterone dermatitis |
|---|
| Anmerkungen: |
Date Completed 23.05.2018 Date Revised 31.05.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.iac.2017.07.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM27635446X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM27635446X | ||
| 003 | DE-627 | ||
| 005 | 20231225011825.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.iac.2017.07.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0921.xml |
| 035 | |a (DE-627)NLM27635446X | ||
| 035 | |a (NLM)28965640 | ||
| 035 | |a (PII)S0889-8561(17)30079-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Foer, Dinah |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Progestogen Hypersensitivity |b An Evidence-Based Approach to Diagnosis and Management in Clinical Practice |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.05.2018 | ||
| 500 | |a Date Revised 31.05.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2017 Elsevier Inc. All rights reserved. | ||
| 520 | |a Heterogeneous presentations of disease pose particular diagnostic and management challenges to the clinician. Progestogen hypersensitivity (PH) classically consists of hypersensitivity symptoms to endogenous progesterone during the luteal phase of the menstrual cycle. However, with the rise of assisted fertility and the exponential growth in the use of exogenous progestins for contraception, PH's prevalence and symptom heterogeneity have increased. In this article, we focus on the clinical approach to PH diagnosis with an emphasis on key elements of the history, physical, and testing modalities. We also review the current evidence for successful management and treatment across a broad range of patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Autoimmune progesterone dermatitis | |
| 650 | 4 | |a Desensitization | |
| 650 | 4 | |a In vitro fertilization | |
| 650 | 4 | |a Progesterone | |
| 650 | 4 | |a Progestin | |
| 650 | 4 | |a Progestogen hypersensitivity | |
| 650 | 7 | |a Progestins |2 NLM | |
| 700 | 1 | |a Buchheit, Kathleen M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Immunology and allergy clinics of North America |d 1990 |g 37(2017), 4 vom: 01. Nov., Seite 773-784 |w (DE-627)NLM087751623 |x 1557-8607 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2017 |g number:4 |g day:01 |g month:11 |g pages:773-784 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.iac.2017.07.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2017 |e 4 |b 01 |c 11 |h 773-784 | ||